The company's financial stability appears compromised by an accumulated deficit of $180.6M in retained earnings and a reliance on $2.4M in goodwill, which may be subject to future impairment charges.
| Total Current Assets | 8.38M | 6.55M | 6.39M | 8.07M | 16.01M | 36.5M | 23.71M | 15.74M | 11.79M | 3.69M | 956.32K |
| Cash & Short-Term Investments | 2.64M | 2.26M | 2.45M | 1.8M | 7.72M | 27.44M | 15.1M | 5.49M | 6.49M | 1.14M | 34.26K |
| Cash Only | 2.64M | 2.26M | 2.45M | 1.8M | 6.72M | 26.41M | 14.82M | 4.69M | 4.28M | 284.25K | 34.26K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 1M | 1.03M | 276.47K | 798.54K | 2.21M | 859.11K | 0 |
| Accounts Receivable | 1.57M | 1.04M | 983.91K | 1.22M | 1.45M | 1.11M | 911.48K | 2.67M | 4.2M | 1.38M | 163.97K |
| Days Sales Outstanding | 21.46 | 19.8 | 18.43 | 18.38 | 14.93 | 9.14 | 7.94 | 41.14 | 3.34K | 112.48 | 29.46 |
| Inventory | 3.65M | 2.95M | 2.37M | 4.05M | 4.26M | 5.02M | 4.89M | 4.3M | 123.22K | 588.2K | 687.47K |
| Days Inventory Outstanding | 134.41 | 148.93 | 99.96 | 133.05 | 104.26 | 118.16 | 115.08 | 171.84 | 137.73 | 158.4 | 155.04 |
| Other Current Assets | 520.11K | 277.15K | 406.67K | 750.38K | 703.32K | 1.16M | 1.39M | 1.3M | 589.54K | 583.15K | 0 |
| Total Non-Current Assets | 3.87M | 3.87M | 4.19M | 8.13M | 24.78M | 88.38M | 87.13M | 78.78M | 3.23M | 3.38M | 667.04K |
| Property, Plant & Equipment | 722.68K | 1.04M | 602.79K | 4.07M | 5.55M | 8.71M | 10.83M | 2.47M | 53.48K | 135.48K | 180.28K |
| Fixed Asset Turnover | 20.14x | 18.38x | 32.32x | 5.94x | 6.38x | 5.11x | 3.87x | 9.58x | 8.58x | 33.03x | 11.27x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 56.67M | 54.67M | 54.67M | 0 | 0 | 0 |
| Intangible Assets | 2.38M | 2.12M | 2.89M | 3.22M | 17.83M | 23.12M | 21.64M | 21.64M | 3.17M | 3.24M | 486.76K |
| Long-Term Investments | 2.8M | 700K | 700K | 700K | 1.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 62.71K | 0 | 0 | 138.71K | 1.64B | -114.18K | 0 | 0 | 0 | -2.44B | 0 |
| Total Assets | 12.25M | 10.42M | 10.58M | 16.2M | 40.79M | 124.88M | 110.84M | 94.52M | 15.02M | 7.07M | 1.62M |
| Asset Turnover | 1.80x | 1.84x | 1.84x | 1.49x | 0.87x | 0.36x | 0.38x | 0.25x | 0.03x | 0.63x | 1.25x |
| Asset Growth % | -15.95% | -1.53% | -34.66% | -60.3% | -67.34% | 12.67% | 17.27% | 529.38% | 112.43% | 335.48% | - |
| Total Current Liabilities | 2.97M | 3.19M | 8.62M | 4.67M | 5.29M | 6.92M | 7.69M | 3.71M | 969.96K | 1.52M | 1.9M |
| Accounts Payable | 1.39M | 1.17M | 1.54M | 1.91M | 2.04M | 2.98M | 2.85M | 3.02M | 481.58K | 465.48K | 206.16K |
| Days Payables Outstanding | 9.65K | 59.31 | 65.13 | 62.58 | 49.89 | 70.09 | 67.06 | 120.7 | 538.27 | 125.35 | 46.49 |
| Short-Term Debt | 415.13K | 778.24M | 1.17M | 2.49K | 9.61K | 59.47K | 2.07M | 0 | 0 | 0 | 797.55K |
| Deferred Revenue (Current) | 490.1M | 506.29M | 503.25K | 185.25K | 0 | 0 | 45.14K | 7.34K | 161.46K | 41.42K | 0 |
| Other Current Liabilities | 705.53K | -1.28B | 0 | 0 | 0 | 0 | 2.72M | 0 | 0 | 0 | 0 |
| Current Ratio | 2.82x | 2.05x | 0.74x | 1.73x | 3.03x | 5.28x | 3.08x | 4.24x | 12.16x | 2.42x | 0.50x |
| Quick Ratio | 1.59x | 1.13x | 0.47x | 0.86x | 2.22x | 4.55x | 2.45x | 3.08x | 12.03x | 2.04x | 0.14x |
| Cash Conversion Cycle | -9.49K | 109.42 | 53.26 | 88.84 | 69.29 | 57.21 | 55.96 | 92.29 | 2.94K | 145.52 | 138.01 |
| Total Non-Current Liabilities | 0 | 0 | 0 | 2.49M | 4.08M | 14.82M | 23.97M | 53.2M | 28.5K | 397K | 12K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 602.1K | 0 | 0 | 360K | 0 |
| Capital Lease Obligations | 201.24K | 0 | 0 | 2.4M | 3.68M | 4.86M | 6.01M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 895K | 2.24M | 21K | 37K | 12K |
| Other Non-Current Liabilities | 0 | 0 | 0 | 90.37K | 401.49K | 9.96M | 16.46M | 50.96M | 7.5K | 0 | 0 |
| Total Liabilities | 2.97M | 3.19M | 8.62M | 7.16M | 9.37M | 21.74M | 31.66M | 56.91M | 998.46K | 1.92M | 1.92M |
| Total Debt | 415.13K | 778.24M | 1.27M | 3.68M | 4.87M | 6.07M | 8.68M | 194.47K | 0 | 360K | 797.55K |
| Net Debt | -2.22M | 775.98M | -1.18M | 1.89M | -1.85M | -20.34M | -6.14M | -4.5M | -4.28M | 75.75K | 763.29K |
| Debt / Equity | 0.04x | 107.70x | 0.65x | 0.41x | 0.15x | 0.06x | 0.11x | 0.01x | - | 0.07x | - |
| Debt / EBITDA | -0.43x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 2.32x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | -108.10x | - | - | -678.05x | - | - | -1881.75x | -0.48x | -24.09x |
| Total Equity | 9.28M | 7.23M | 1.96M | 9.03M | 31.42M | 103.14M | 79.18M | 37.6M | 14.02M | 5.15M | -292.73K |
| Equity Growth % | 2069.97% | 268.04% | -78.26% | -71.26% | -69.53% | 30.26% | 110.57% | 168.23% | 172.27% | 1858.96% | - |
| Book Value per Share | 0.89 | 1.80 | 0.46 | 4.47 | 23.67 | 84.48 | 78.88 | 94.60 | 81.40 | 30.93 | -3.19 |
| Total Shareholders' Equity | 9.28M | 7.23M | 1.96M | 9.03M | 31.42M | 103.14M | 79.18M | 37.6M | 12.61M | 4.21M | 363.43K |
| Common Stock | 10.5K | 8.92K | 3.94K | 2.96K | 60.67K | 57.78K | 52.13K | 27.72K | 8.12K | 5.79K | 3.4K |
| Retained Earnings | -180.64M | -179.44M | -182.07M | -174.36M | -147.42M | -73.34M | -47.39M | -59.61M | -6.67M | -6.26M | -4.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.51M | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.41M | 937.06K | -656.15K |
Liquidity and insolvency risk
According to recent financial disclosures, YCBD's total assets have contracted from $15.1M in 2024Q1 to $12.3M in 2026Q2, signaling a persistent decline in the company's resource base as it struggles to maintain operational scale within a highly competitive and fragmented hemp-derived wellness market.
The consistent reduction in total assets suggests that the company is failing to replace its asset base as it consumes capital to fund ongoing operations. This downward trajectory in asset value, coupled with stagnant revenue, implies that the business model is currently unable to generate the internal growth necessary to stabilize its financial position.
Based on the 2026Q2 balance sheet, YCBD maintains a cash position of $2.6M, which, while providing a current ratio of 2.82, remains insufficient to offset the structural cash burn and the significant uncertainty surrounding future revenue generation in the discretionary wellness sector.
While the current ratio appears superficially healthy, it is heavily influenced by the composition of current assets which may include slow-moving inventory. Investors should monitor whether this liquidity buffer is sufficient to cover upcoming operational obligations, as the company's history of negative cash flow suggests that this cash runway may be shorter than the headline ratio implies.
As reported in recent filings, YCBD's retained earnings have plummeted to a deficit of $180.6M as of 2026Q2, reflecting years of value-destructive capital allocation and the persistent inability of the core business to achieve sustained profitability despite its premium brand positioning.
The massive accumulated deficit indicates that the company has consistently failed to generate returns on invested capital, effectively eroding shareholder equity over time. This trend suggests that the current equity base is largely a function of historical financing rather than retained value, leaving little margin for error in future strategic execution.
Data from the latest balance sheet indicates that goodwill remains at $2.4M, a figure that warrants further investigation given the company's declining revenue and the potential for future impairment charges if the Paw CBD and cbdMD brands fail to meet long-term performance expectations.
The presence of significant goodwill on a shrinking balance sheet suggests that the carrying value of past acquisitions may be overstated relative to current market realities. If management is forced to write down these intangible assets, it would further weaken an already strained equity position and potentially trigger restrictive covenants on existing debt.
Quick answers to the most common questions about buying YCBD stock.
As of 2025, cbdMD, Inc. (YCBD) had total assets of $10.4M including $6.6M in current assets.
cbdMD, Inc. (YCBD) carries total debt of $778.2M, offset by $2.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
cbdMD, Inc. (YCBD) has total shareholders' equity (book value) of $7.2M ($1.80 book value per share). Book value represents the net worth of the company belonging to common stock holders.
cbdMD, Inc. (YCBD) reported a current ratio of 2.05x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.